The 700kHz, 260-element histotripsy ultrasound array transducer used in Prof. Xu’s lab.
Image credit: Marcin Szczepanski, Michigan Engineering
Technique pioneered in rats at the University of Michigan could improve outcomes for cancer and neurological conditions
Noninvasive sound technology developed at the University of Michigan breaks down liver tumors in rats, kills cancer cells and spurs the immune system to prevent further spread—an advance that could lead to improved cancer outcomes in humans.
By destroying only 50% to 75% of liver tumor volume, the rats’ immune systems were able to clear away the rest, with no evidence of recurrence or metastases in more than 80% of animals.
“Even if we don’t target the entire tumor, we can still cause the tumor to regress and also reduce the risk of future metastasis,” said Zhen Xu, professor of biomedical engineering at U-M and corresponding author of the study in Cancers.
Results also showed the treatment stimulated the rats’ immune responses, possibly contributing to the eventual regression of the untargeted portion of the tumor and preventing further spread of the cancer.
The treatment, called histotripsy, noninvasively focuses ultrasound waves to mechanically destroy target tissue with millimeter precision. The relatively new technique is currently being used in a human liver cancer trial in the United States and Europe.
In many clinical situations, the entirety of a cancerous tumor cannot be targeted directly in treatments for reasons that include the mass’ size, location or stage. To investigate the effects of partially destroying tumors with sound, this latest study targeted only a portion of each mass, leaving behind a viable intact tumor. It also allowed the team, including researchers at Michigan Medicine and the Ann Arbor VA Hospital, to show the approach’s effectiveness under less than optimal conditions.
“Histotripsy is a promising option that can overcome the limitations of currently available ablation modalities and provide safe and effective noninvasive liver tumor ablation,” said Tejaswi Worlikar, a doctoral student in biomedical engineering. “We hope that our learnings from this study will motivate future preclinical and clinical histotripsy investigations toward the ultimate goal of clinical adoption of histotripsy treatment for liver cancer patients.”
Liver cancer ranks among the top 10 causes of cancer related deaths worldwide and in the U.S. Even with multiple treatment options, the prognosis remains poor with five-year survival rates less than 18% in the U.S. The high prevalence of tumor recurrence and metastasis after initial treatment highlights the clinical need for improving outcomes of liver cancer.
Where a typical ultrasound uses sound waves to produce images of the body’s interior, U-M engineers have pioneered the use of those waves for treatment. And their technique works without the harmful side effects of current approaches such as radiation and chemotherapy.
“Our transducer, designed and built at U-M, delivers high amplitude microsecond-length ultrasound pulses—acoustic cavitation—to focus on the tumor specifically to break it up,” Xu said. “Traditional ultrasound devices use lower amplitude pulses for imaging.”
The microsecond long pulses from UM’s transducer generate microbubbles within the targeted tissues—bubbles that rapidly expand and collapse. These violent but extremely localized mechanical stresses kill cancer cells and break up the tumor’s structure.
Since 2001, Xu’s laboratory at U-M has pioneered the use of histotripsy in the fight against cancer, leading to the clinical trial #HOPE4LIVER sponsored by HistoSonics, a U-M spinoff company. More recently, the group’s research has produced promising results on histotripsy treatment of brain therapy and immunotherapy.
Original Article: Tumors partially destroyed with sound don’t come back
More from: University of Michigan
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Histotripsy
- GEORGIA HOSPITAL SUCCESSFULLY PERFORMS FIRST NON-INVASIVE LIVER CANCER TREATMENT IN THE STATE
May 2, 2024 /PRNewswire/ -- Patients with liver cancer in the southeast can stay closer to home and trust they'll receive the latest, most advanced care as Northeast Georgia Medical Center (NGMC) ...
- Buford man first in Georgia to undergo new liver cancer procedure
At the same time, Dr. Nelson Royall, Reid's surgeon at Northeast Georgia Medical Center, was exploring a new option for patients with liver cancer: histotripsy, using sound waves to destroy tumor ...
- Noninvasive liver cancer treatment now offered in Seattle's First Hill: HealthLink
The new treatment is called "Histotripsy" and uses ultrasound waves to target tumors and eliminates the need for patients to undergo surgery.
- Northeast Georgia Medical Center Gainesville performs first of its kind liver cancer treatment
Northeast Georgia Medical Center Gainesville recently performed a first-of-its-kind non-invasive liver cancer treatment.
- Health research benefits both ends of the leash
Histotripsy is a non-invasive, focused ultrasound method that mechanically breaks up tissues using controlled ultrasound pulses. It has been effectively used to treat liver cancer in humans and is now ...
Go deeper with Google Headlines on:
Histotripsy
[google_news title=”” keyword=”histotripsy” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Ultrasound transducer
- Touro University Nevada College of Osteopathic Medicine Teaches Living Anatomy and Physiology with Vave Health Pocket Ultrasound
Largest Medical School in Nevada Provides Every Student with Wireless, Portable UltrasoundSAN JOSE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Vave Health, the company on a mission to put ultrasound in ...
- Provisio SLT IVUS System Cleared by FDA
Provisio Medical announced FDA 510(k) clearance of the Provisio sonic lumen tomography (SLT) intravascular ultrasound (IVUS) syst ...
- Technion breakthrough for better drug delivery and tissue implantation
Researchers develop ultrasound for non-invasive method for bio-printing live cells and tissues deep within the body.
- Technion scientists harness ultrasound for drug delivery and tissue implantation
Ultrasound: In the researchers' innovative method, cells or drugs are delivered within a biological fluid ink directly to the treated area deep within the body through direct injection or ...
- Scientists harness ultrasound for drug delivery and tissue implantation
Research presents an advance in drug delivery and tissue implantation assisted by ultrasound, developed by researchers from the Technion Faculty of Biomedical Engineering. The work is published in the ...
Go deeper with Google Headlines on:
Ultrasound transducer
[google_news title=”” keyword=”ultrasound transducer” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]